Checkpoint genes, ageing, and the development of cancer

Oncogene

Volumn 23, Issue 47, 2004, Pages 7799-7809

  Wodarz, Dominik ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUTE FOR ADVANCED STUDY   (United States)

Author keywords

Computational; Mathematical; p53

Indexed keywords

ARTICLE; CANCER GENETICS; CANCER INHIBITION; CARCINOGENESIS; CELL AGING; CELL GROWTH; DNA DAMAGE; HUMAN; MATHEMATICAL MODEL; PRIORITY JOURNAL;

AGING; CELL DIVISION; GENES, CDC; HUMANS; MODELS, GENETIC; MODELS, THEORETICAL; NEOPLASMS; REFERENCE VALUES;

EID: 7644232633     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207833     Document Type: Article

References (34)

1. Bayko L, Rak J, Man S, Bicknell R, Ferrara N and Kerbel RS. (1998). Angiogenesis, 2, 203-217.
2. Blagosklonny MV. (2002). Int. J. Cancer, 98, 161-166.
3. Campisi J. (2001). Scientific World J., 1, 65.
4. Campisi J. (2003). Nat. Rev. Cancer, 3, 339-349.
5. Camplejohn RS, Gilchrist R, Easton D, McKenzie-Edwards E, Barnes DM, Eccles DM, Ardern-Jones A, Hodgson SV, Duddy PM and Eeles RA. (2003). Br. J. Cancer, 88, 487-490.
6. Chavez-Reyes A, Parant JM, Amelse LL, de Oca Luna RM, Korsmeyer SJ and Lozano G. (2003). Cancer Res., 63, 8664-8669.
7. Cunha GR and Matrisian LM. (2002). Differentiation, 70, 469-472.
8. Donehower LA. (2002). J. Cell. Physiol., 192, 23-33.
9. Evans SC and Lozano G. (1997). Mol. Med. Today, 3, 390-395.
10. Finkel T and Holbrook NJ. (2000). Nature, 408, 239-247.
11. Folkman J. (2002). Semin. Oncol., 29, 15-18.
12. Folkman J and Kalluri R. (2004). Nature, 427, 787.
13. Gilhar A, Ullmann Y, Karry R, Shalaginov R, Assy B, Serafimovich S and Kalish RS. (2004). Br. J. Dermatol., 150, 56-63.
14. Guba M, Cernaianu G, Koehl G, Geissler EK, Jauch KW, Anthuber M, Falk W and Steinbauer M. (2001). Cancer Res., 61, 5575-5579.
15. Hahnfeldt P, Panigrahy D, Folkman J and Hlatky L. (1999). Cancer Res., 59, 4770-4775.
16. Hasty P, Campisi J, Hoeijmakers J, van Steeg H and Vijg J. (2003). Science, 299, 1355-1359.
17. Hsu MY, Meier F and Herlyn M. (2002). Differentiation, 70, 522-536.
18. Itahana K, Dimri G and Campisi J. (2001). Eur. J. Biochem, 268, 2784-2791.
19. Jansen-Durr P. (2002). Scientific World J., 2, 943-948.
20. Kahlem P, Borken B and Schmitt CA. (2004). J. Clin. Invest., 113, 169-174.
21. Kemp CJ, Donehower LA, Bradley A and Balmain A. (1993). Cell, 74, 813-822.
22. Kirkwood TB. (2002). Bio Essays, 24, 577-579.
23. Komarova NL and Wodarz D. (2003). Cancer Res., 63, 6635-6642.
24. Lengauer C, Kinzler KW and Vogelstein B. (1998). Nature, 396, 643-649.
25. Mueller MM and Fusenig NE. (2002). Differentiation, 70, 486-497.
26. Offer H, Erez N, Zurer I, Tang X, Milyavsky M, Goldfinger N and Rotter V. (2002). Carcinogenesis, 23, 1025-1032.
27. Oren M. (2003). Cell Death Differ., 10, 431-442.
28. Parrinello S, Samper E, Krtolica A, Goldstein J, Melov S and Campisi J. (2003). Nat. Cell. Biol., 5, 741-747.
29. Schmitt CA. (2003). Nat. Rev. Cancer, 3, 286-295.
30. Sharpless NE and DePinho RA. (2002). Cell, 110, 9-12.
31. Tlsty TD. (2001). Semin. Cancer Biol., 11, 97-104.
32. Tlsty TD and Hein PW. (2001). Curr. Opin. Genet. Dev., 11, 54-59.
33. Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H, Lu X, Soron G, Cooper B, Brayton C, Hee Park S, Thompson T, Karsenty G, Bradley A and Donehower LA. (2002). Nature, 415, 45-53.
34. Vogelstein B, Lane D and Levine AJ. (2000). Nature, 408, 307-310.